References
- Leon Shargel, Izzy Kanfer. (2005). Generic drug product development- solid oral dosage forms. In: Leon, Shargel, and Izzy, Kanfer. (Eds.), Introduction to Generic drug development. Chapter 1. N.Y. USA:Marcel Dekker Inc. p 1–3.
- Abdelbary GA, Tadros MI. Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer. Eur J Pharm Biopharm 2008;69:1019–1028.
- Varshosaz J, Tavakoli N, Kheirolahi F. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. AAPS PharmSciTech 2006, 7: Article 24
- Taludar M, Michoel A, Rombaut P, Kinget R. Comparative study on xanthan gum and hydroxypropylmethylcellulose as matrices for controlled- release drug delivery 1. Compaction and in vitro drug release behavior. Int J Pharmaceut1996; 129: 233–241.
- Phaechamud T, Ritthidej GC. Sustained-release from layered matrix system comprising chitosan and xanthan gum. Drug Dev Ind Pharm 2007;33:595–605.
- Argin-Soysal S, Kofinas P, Martin Y. Effect of complexation conditions on xanthan–chitosan polyelectrolyte complex gels. Food Hydrocolloids 2009; 23: 202–209
- Fukuda M, Peppas NA, McGinity JW. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum. Int J Pharm 2006;310:90–100.
- Gerrit Borchard. Chitosans for gene delivery. Adv Drug Deliv Rev 2001; 52: 145–150.
- García-Ochoa F, Santos VE, Casas JA, Gómez E. Xanthan gum: production, recovery, and properties. Biotechnol Adv 2000;18:549–579.
- Qin Y. Review, Alginate fibres: An overview of the production processes and applications in wound management. Polymer international 2008; 57: 171– 180
- Vendruscolo CW, Andreazza IF, Ganter JL, Ferrero C, Bresolin TM. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline. Int J Pharm 2005;296:1–11.
- Taludar MM, Kinget R. Comparative study on xanthangum and hydroxypropylmethylcellulose as matrices for controlled- release drug delivery II. Drug diffusion in hydrated matrices. Int J Pharm 1997; 151: 99–107.
- Ahuja S, Ashman J. Terbutaline sulfate.. In: Florey Ked. Analytical Profiles of Drug Substances, Academic Press, 1990, 19, 603–625
- Daraghmeh N, Al-Omari MM, Sara Z, Badwan AA, Jaber AM. Determination of terbutaline sulfate and its degradation products in pharmaceutical formulations using LC. J Pharm Biomed Anal 2002;29:927–937.
- Paradeep M. Sathe Andre S. Raw, Larry A. Quaderkirk, Lawrence X. Yu and Ajaz, S Hussain. (2005).Generic drug product development− solid oral dosage forms. In: Leon Shargel and Izzy Kanfer eds.Drug Product Performance, in Vitro. Chapter 8, N.Y. USA: Marcel Dekker Inc., p187–209.
- Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145–1149.
- Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983; 15: 25–35.
- Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110–111.
- Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem 1931; 23: 923–931.
- Sujja-areevath J, Munday DL, Cox PJ, Khan KA. Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations. Eur J Pharm Sci 1998;6:207–217.
- Sriamornsak P, Thirawong N, Korkerd K. Swelling, erosion and release behavior of alginate-based matrix tablets. Eur J Pharm Biopharm 2007;66:435–450.
- Chellat F, Tabrizian M, Dumitriu S, Chornet E, Magny P, Rivard CH et al. In vitro and in vivo biocompatibility of chitosan-xanthan polyionic complex. J Biomed Mater Res 2000;51:107–116.
- Mitrevej A, Sinchaipanid N, Rungvejhavuttivittaya Y, Kositchaiyong V. Multiunit controlled-release diclofenac sodium capsules using complex of chitosan with sodium alginate or pectin. Pharm Dev Technol 2001;6:385–392.
- Takahashi T, Takayama K, Machida Y, Nagai T. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int J Pharm 1990; 61: 35–41
- FDA, September 1997, Guidance for Industry: SUPAC-MR: Extended Release Oral Dosage Forms; Development, Evaluation, and Application of In Vitro/In Vivo Correlations.